Health
Two repurposed drugs and a blue dye show potential as SARS-CoV-2 entry inhibitors – News-Medical.Net
A new multidisciplinary study from Australia, published in the open-access journal mBio, shows that three compounds used to treat cystic fibrosis, dry eye, and…
A new multidisciplinary study from Australia, published in the open-access journal mBio, shows that three compounds used to treat cystic fibrosis, dry eye, and a specific medical dye may lead to future strategies for the treatment of coronavirus disease (COVID-19).
The ongoing pandemic of COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a health emergency that necessitates the continued use of vaccines, but also the development of new drugs to prevent…
-
Business13 hours agoWarning! These ASX 200 shares were just downgraded
-
Business10 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
Business12 hours agoAfter falling more than 20% on its FY25 result, are Inghams shares a buy the dip opportunity?
-
Noosa News12 hours agoSwimmers rescued | Noosa Today